Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17326InvestigationalGene Therapies
Delolimogene mupadenorepvec: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Tumor necrosis factor receptor superfamily member 5 and Tumor necrosis factor receptor superfamily member 9
- Also known as
- Dna (synthetic human adenovirus 5/35 vector load703 human cd137 ligand and trimerized membrane-bound isoleucine zipper-containing human cd40 ligand-specifying)
- Code names
- LOAd703
Resolves to
Compound
Targets
What you can answer from here — as of October 05, 2026
Which drugs share a target with Delolimogene mupadenorepvec, and which of those have an active Phase 3 trial?